Dronabinol is assessed for a pregnancy Group C drug, mainly because it has not exhibited teratogenic outcomes in animal types at doses starting from 0.2 to five instances the maximum proposed human dose. Having said that, it is important to notice that pregnant people have not been subjected to sufficiently controlled studies.The result is some Tre